Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 22, 2022

SELL
$36.28 - $75.29 $124,512 - $258,395
-3,432 Closed
0 $0
Q1 2022

Apr 22, 2022

BUY
$69.73 - $142.9 $239,313 - $490,432
3,432 New
3,432 $253,000

Others Institutions Holding NVAX

About NOVAVAX INC


  • Ticker NVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,215,104
  • Market Cap $680M
  • Description
  • Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...
More about NVAX
Track This Portfolio

Track Alpha Cubed Investments, LLC Portfolio

Follow Alpha Cubed Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpha Cubed Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpha Cubed Investments, LLC with notifications on news.